{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:10:01Z","timestamp":1791007801350,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":1919,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1593\/neo.81352","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:00:07Z","timestamp":1429794007000},"page":"187-195","source":"Crossref","is-referenced-by-count":42,"title":["Cyclophosphamide Enhances Human Tumor Growth in Nude Rat Xenografted Tumor Models"],"prefix":"10.1016","volume":"11","author":[{"given":"Yingjen","family":"Jeffrey Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie L.","family":"Muldoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana Thomas","family":"Dickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csanad G.","family":"Varallyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Neuwelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.81352_bib1","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1126\/science.1127592","article-title":"Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors","volume":"313","author":"Shaked","year":"2006","journal-title":"Science"},{"key":"10.1593\/neo.81352_bib2","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1158\/0008-5472.CAN-05-4411","article-title":"Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy","volume":"66","author":"Munoz","year":"2006","journal-title":"Cancer Res"},{"key":"10.1593\/neo.81352_bib3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1164\/ajrccm.154.6.8970380","article-title":"Lung toxicity associated with cyclophosphamide use. Two distinct patterns","volume":"154","author":"Malik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1593\/neo.81352_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/annonc\/mdg204","volume":"14","author":"Bernard-Marty","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1593\/neo.81352_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0022-5347(17)36156-6","article-title":"Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener's granulomatosis: a report of 2 cases","volume":"149","author":"Stein","year":"1993","journal-title":"J Urol"},{"key":"10.1593\/neo.81352_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.1780310402","article-title":"Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis","volume":"31","author":"Stillwell","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1593\/neo.81352_bib7","first-page":"997","article-title":"Metastases of human tumors in experimental animals","volume":"7","author":"Dore","year":"1987","journal-title":"Anticancer Res"},{"key":"10.1593\/neo.81352_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrd1635","article-title":"What's wrong with our cancer models?","volume":"4","author":"Kamb","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1593\/neo.81352_bib9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/11320","article-title":"Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses","volume":"5","author":"Ikeda","year":"1999","journal-title":"Nat Med"},{"key":"10.1593\/neo.81352_bib10","doi-asserted-by":"crossref","first-page":"11255","DOI":"10.1158\/0008-5472.CAN-05-2278","article-title":"Cyclophosphamide allows for in vivo dose reduction of a potent oncolytic virus","volume":"65","author":"Kambara","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.81352_bib11","doi-asserted-by":"crossref","first-page":"12873","DOI":"10.1073\/pnas.0605496103","article-title":"Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses","volume":"103","author":"Fulci","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.81352_bib12","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2004-06-2410","article-title":"Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide","volume":"105","author":"Lutsiak","year":"2005","journal-title":"Blood"},{"key":"10.1593\/neo.81352_bib13","first-page":"141","article-title":"Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide","volume":"16","author":"Motoyoshi","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1593\/neo.81352_bib14","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.1158\/0008-5472.CAN-04-3808","article-title":"Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells","volume":"65","author":"Honeychurch","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.81352_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/0008-5472.CAN-07-3063","article-title":"Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy","volume":"68","author":"Yamauchi","year":"2008","journal-title":"Cancer Res"},{"key":"10.1593\/neo.81352_bib16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ijc.2910150408","article-title":"Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection","volume":"15","author":"van Putten","year":"1975","journal-title":"Int J Cancer"},{"key":"10.1593\/neo.81352_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000220528","article-title":"Duration of drug levels in mice as indicated by residual antileukemic efficacy","volume":"13","author":"Kline","year":"1968","journal-title":"Chemotherapy"},{"key":"10.1593\/neo.81352_bib18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1158\/1078-0432.CCR-06-2082","article-title":"Reactive oxygen species: a breath of life or death?","volume":"13","author":"Fruehauf","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"Suppl 2","key":"10.1593\/neo.81352_bib19","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1016\/S0753-3322(05)80070-8","article-title":"Tumor angiogenesis and therapy","volume":"59","author":"Cao","year":"2005","journal-title":"Biomed Pharmacother"},{"key":"10.1593\/neo.81352_bib20","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2174\/092986706777585059","article-title":"Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic","volume":"13","author":"Ranieri","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1593\/neo.81352_bib21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1124\/jpet.103.063347","article-title":"Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model","volume":"309","author":"Neuwelt","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1593\/neo.81352_bib22","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1158\/1078-0432.CCR-06-2379","article-title":"Characterization and magnetic resonance imaging of a rat model of human B-cell central nervous system lymphoma","volume":"13","author":"Soussain","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.81352_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0040-8166(97)80066-3","article-title":"Ultrastructural changes of stromal cells of bone marrow and liver after cyclophosphamide treatment in mice","volume":"29","author":"Anton","year":"1997","journal-title":"Tissue Cell"},{"key":"10.1593\/neo.81352_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0300-483X(02)00033-1","article-title":"Blood and spleen lymphocytes as targets for immunotoxic effects in the rat-a comparison","volume":"174","author":"Nygaard","year":"2002","journal-title":"Toxicology"},{"key":"10.1593\/neo.81352_bib25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","article-title":"Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients","volume":"56","author":"Ghiringhelli","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1593\/neo.81352_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1593\/neo.81352_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","article-title":"Macrophages: obligate partners for tumor cell migration, invasion, and metastasis","volume":"124","author":"Condeelis","year":"2006","journal-title":"Cell"},{"key":"10.1593\/neo.81352_bib28","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/ATVBAHA.107.151456","article-title":"PECAM-1: a multi-functional molecule in inflammation and vascular biology","volume":"27","author":"Woodfin","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1593\/neo.81352_bib29","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1468-1331.2006.01640.x","article-title":"PECAM-1, a key player in neuroinflammation","volume":"13","author":"Kalinowska","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1593\/neo.81352_bib30","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.bbamcr.2007.05.006","article-title":"Up-regulation of VEGF expression by NGF that enhances reparative angiogenesis during thymic regeneration in adult rat","volume":"1773","author":"Park","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1593\/neo.81352_bib31","first-page":"1878","article-title":"Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer","volume":"60","author":"Browder","year":"2000","journal-title":"Cancer Res"},{"key":"10.1593\/neo.81352_bib32","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1600-0609.2007.00831.x","article-title":"Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation","volume":"78","author":"Mauro","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1593\/neo.81352_bib33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1582-4934.2004.tb00319.x","article-title":"The involvement of endothelial progenitor cells in tumor angiogenesis","volume":"8","author":"Ribatti","year":"2004","journal-title":"J Cell Mol Med"},{"key":"10.1593\/neo.81352_bib34","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1158\/0008-5472.CAN-07-6705","article-title":"Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice","volume":"68","author":"Dineen","year":"2008","journal-title":"Cancer Res"},{"key":"10.1593\/neo.81352_bib35","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat Med"},{"key":"10.1593\/neo.81352_bib36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1126\/science.1082504","article-title":"Tumor response to radiotherapy regulated by endothelial cell apoptosis","volume":"300","author":"Garcia-Barros","year":"2003","journal-title":"Science"},{"key":"10.1593\/neo.81352_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1593\/neo.05592","article-title":"Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer","volume":"8","author":"Goon","year":"2006","journal-title":"Neoplasia"},{"key":"10.1593\/neo.81352_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00132750","article-title":"YIGSR, a synthetic laminin peptide, inhibits the enhancement by cyclophosphamide of experimental lung metastasis of human fibrosarcoma cells","volume":"10","author":"Iwamoto","year":"1992","journal-title":"Clin Exp Metastasis"},{"key":"10.1593\/neo.81352_bib39","first-page":"145","article-title":"The effect of cyclophosphamide and other drugs on the incidence of pulmonary metastases in mice","volume":"37","author":"Carmel","year":"1977","journal-title":"Cancer Res"},{"key":"10.1593\/neo.81352_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/B:CBTO.0000013342.17370.16","article-title":"Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice","volume":"19","author":"Manda","year":"2003","journal-title":"Cell Biol Toxicol"},{"key":"10.1593\/neo.81352_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.etp.2007.06.006","article-title":"Increased glutathione levels and activity of PON1 (phenyl acetate esterase) in the liver of rats after a single dose of cyclophosphamide: a defense mechanism?","volume":"59","author":"Abraham","year":"2008","journal-title":"Exp Toxicol Pathol"},{"key":"10.1593\/neo.81352_bib42","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.freeradbiomed.2004.02.067","article-title":"Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis","volume":"36","author":"Lopez","year":"2004","journal-title":"Free Radic BiolMed"},{"key":"10.1593\/neo.81352_bib43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00204-005-0655-7","article-title":"Chemoprotective effects of captopril against cyclophosphamide-induced genotoxicity in mouse bone marrow cells","volume":"79","author":"Hosseinimehr","year":"2005","journal-title":"Arch Toxicol"},{"key":"10.1593\/neo.81352_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cccn.2003.08.013","article-title":"Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serumof patients with chronic lymphocytic leukemia","volume":"338","author":"Bakan","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1593\/neo.81352_bib45","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V80.8.2038.2038","article-title":"Glutathione depletion in chronic lymphocytic leukemia B lymphocytes","volume":"80","author":"Silber","year":"1992","journal-title":"Blood"},{"key":"10.1593\/neo.81352_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00689268","article-title":"Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat","volume":"27","author":"Genka","year":"1990","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558609800316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558609800316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T07:13:06Z","timestamp":1598944386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558609800316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1476558609800316"],"URL":"https:\/\/doi.org\/10.1593\/neo.81352","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}